HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
TB FragHPLC ≥ 99%MS confirmed2mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | TB Frag (Ac-SDKP) |
|---|---|
| CAS number | 120081-14-3 |
| Molecular formula | C20H33N5O9 |
| Molecular weight | 487.5 g/mol |
| Sequence | Ac-SDKP (Ac-Ser-Asp-Lys-Pro) |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 2mg / 5mg / 10mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; short-term ambient transit is tolerated. After reconstitution, keep at 2-8°C and use within a research-defined window. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About TB Frag (Ac-SDKP).
TB Frag (Ac-SDKP) is a naturally occurring tetrapeptide bioregulator cleaved from the N-terminus of thymosin β4. In published preclinical research it has been studied for anti-fibrotic, pro-angiogenic and hematopoietic-regulatory activity, associated in part with the ACE/Ac-SDKP axis and inhibition of prolyl oligopeptidase; it is chemically and functionally distinct from the thymosin β4 17-23 fragment (TB-500).
Documentation
Batch documentation support for TB Frag (Ac-SDKP) lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the TB Frag (Ac-SDKP) reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
TB Frag (Ac-SDKP) — frequently asked by B2B buyers.
What exactly is TB Frag, and how is it different from TB-500?
TB Frag is the N-terminal fragment (residues 1-4) of thymosin β4, sequence Ac-Ser-Asp-Lys-Pro (Ac-SDKP / Goralatide). It is a different molecule from TB-500, which is the acetylated 17-23 actin-binding fragment (Ac-LKKTETQ). We list both as separate SKUs so buyers order the intended peptide.
What documentation ships with each lot?
Each lot ships with a Certificate of Analysis including an HPLC purity chromatogram and mass-spec confirmation against the expected molecular weight (~487.5 g/mol, formula C20H33N5O9). Additional third-party or independent lab verification can be arranged on request.
What vial sizes and minimum order quantity are available?
Standard formats are 2 mg, 5 mg and 10 mg lyophilized vials, with a minimum order of 50 kits (500 vials). Fill weights, bulk powder quantities and custom vialing are available for private-label and OEM programs.
How is the material supplied and shipped?
It is supplied as a lyophilized (freeze-dried) white powder in sealed vials. We offer cold-chain and ambient shipping options and can advise on packaging for international freight; buyers specify the destination and preferred incoterms at RFQ.
Is this material sold for consumer or medical use?
No. It is offered strictly as a research-use raw material and OEM input; we make no consumer, therapeutic or dosing claims. The buyer is responsible for regulatory classification, labeling and import compliance in the destination market. Custom private-label labeling is available.
Related compounds
Related research peptides.
COA library search
Search public COAs for this product.
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.